GOF mutations in PI3K signaling in APDS patients gave us the opportunity to compare the direct effects of a genetically defined overactive PI3Kδ with the observed signaling alterations in CVID. The gene discussed is PIK3CG; the disease is activated PI3K-delta syndrome.